|
METTL3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.534200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.888400E-02 |
| Normal-vs-Stage2 |
5.570400E-01 |
| Normal-vs-Stage3 |
8.242400E-02 |
| Normal-vs-Stage4 |
6.528000E-01 |
| Stage1-vs-Stage2 |
6.507600E-01 |
| Stage1-vs-Stage3 |
1.676910E-03 |
| Stage1-vs-Stage4 |
2.934200E-01 |
| Stage2-vs-Stage3 |
1.206010E-01 |
| Stage2-vs-Stage4 |
4.532800E-01 |
| Stage3-vs-Stage4 |
6.588000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.782300E-02 |
| Normal-vs-AfricanAmerican |
3.759000E-01 |
| Normal-vs-Asian |
7.000000E-01 |
| Caucasian-vs-AfricanAmerican |
5.095400E-01 |
| Caucasian-vs-Asian |
4.481400E-01 |
| AfricanAmerican-vs-Asian |
8.936400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.631800E-02 |
| Normal-vs-Female |
2.229400E-01 |
| Male-vs-Female |
7.957000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.218800E-01 |
| Normal-vs-Extreme_Weight |
9.707500E-02 |
| Normal-vs-Obese |
4.131000E-01 |
| Normal-vs-Extreme_Obese |
9.086000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.510200E-01 |
| Normal_Weight-vs-Obese |
8.954400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.129600E-01 |
| Extreme_Weight-vs-Obese |
3.855600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.565600E-01 |
| Obese-vs-Extreme_Obese |
6.219200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.123050E-01 |
| Normal-vs-Age(41-60Yrs) |
4.544000E-03 |
| Normal-vs-Age(61-80Yrs) |
3.635400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.116200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.679000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.511200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.137160E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.771800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.770200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.135800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.01019999999108E-05 |
| Normal-VS-Type2 PRCC |
7.810300E-04 |
| Normal-VS-KIRP CIMP |
3.055700E-03 |
| Normal-VS-Unclassified PRCC |
8.365000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.62658775337832E-12 |
| Type1 PRCC-VS-KIRP CIMP |
6.19170000000224E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.460400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.565000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.099780E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.457600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.071000E-01 |
| Normal-vs-N1 |
4.300200E-01 |
| Normal-vs-N2 |
1.756450E-03 |
| N0-vs-N1 |
5.715400E-01 |
| N0-vs-N2 |
5.815700E-02 |
| N1-vs-N2 |
5.595600E-02 |
|
|
